Emerging drugs for nosocomial pneumonia
Adamantia Liapikou1, Antoni Torres2
1a 6th Respiratory Department , Sotiria Chest Diseases Hospital , Athens , Greece.
Expert Opinion on Emerging Drugs
|June 28, 2016
Summary
New antibiotics are emerging to combat hospital-acquired pneumonia (HAP), a serious infection. Promising treatments target multidrug-resistant pathogens, offering hope against infections like MRSA and ESBL bacteria.
Area of Science:
- Infectious Diseases
- Pharmacology
- Critical Care Medicine
Background:
- Hospital-acquired pneumonia (HAP) is a significant global nosocomial infection, leading to increased morbidity, mortality, and healthcare costs.
- Prompt and effective antibiotic therapy is crucial for managing HAP, particularly with the rise of multidrug-resistant (MDR) pathogens.
Purpose of the Study:
- To review recent advancements in antibiotic treatment for nosocomial pneumonia.
- To summarize approved and emerging drugs for HAP, focusing on MDR pathogens.
Main Methods:
- Systematic search of PubMed and ClinicalTrials.gov for Phase III clinical trials.
- Inclusion of English-language reports published between 2000 and 2016.
- Focus on antibiotic treatments for nosocomial pneumonia.
Main Results:
- Identified several promising new compounds and combinations for HAP treatment.
- Highlighted drugs effective against specific MDR bacteria, including MRSA and Gram-negative ESBL producers.
Conclusions:
- Tedizolid (oxazolidone), iclaprim (trimethoprim-related), and plazomicin (aminoglycoside) show potential.
- Ceftazidime/avibactam and ceftolozane/tazobactam combinations are effective against MDR Gram-negative bacteria.
- Emerging therapies offer new options for treating challenging nosocomial pneumonia cases.
More Related Videos
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
11.9K
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
12.6K
Related Concept Videos
01:28Pneumonia IV: Management
1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
01:14Atypical Pneumonia
2
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
2
01:30Pneumonia V: Nursing management and Prevention
3.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
01:30Pneumonia I: Introduction
1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
01:16Drugs Used in Upper Respiratory Disorders: Overview
973
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
973